Faeth Therapeutics, Inc. (FTH) vs Nuvectis Pharma, Inc. (NVCT)

Faeth Therapeutics, Inc. and Nuvectis Pharma, Inc. are both Biotechnology companies. Faeth Therapeutics, Inc. and Nuvectis Pharma, Inc. are of similar size ($750.7M and $706.1M). Across the 8 metrics below, Faeth Therapeutics, Inc. leads on 5 and Nuvectis Pharma, Inc. on 3.

Valuation

Metric FTH NVCT Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.91 52.27 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.13 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (505.89%) (6.48%) (28.84%)
Free cash flow yield (21.43%) (4.11%) (23.03%)

Profitability

Metric FTH NVCT Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (195.26%) (233.30%) (57.72%)
Return on assets (176.88%) (122.61%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FTH NVCT Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 30.33% (18.92%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTH NVCT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.69 1.68 4.73
Net debt to EBITDA 0.96 1.15 0.96

Dividend

Metric FTH NVCT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FTH NVCT Biotechnology median
Market cap 750.66m 706.09m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack